Acetaminophen misconceptions

Authors

  • Barry H. Rumack M.D.

    Corresponding author
    1. University of Colorado School of Medicine, Greenwood Village, CO
    • Rocky Mountain Poison and Drug Center, Clinical Professor of Pediatrics, University of Colorado School of Medicine, 33 Silver Fox Circle, Greenwood Village, CO 80121
    Search for more papers by this author
    • fax: (720) 294-1281


Abstract

Examination of the pharmacokinetics of acetaminophen can decrease misconceptions involved in clinical evaluation. Enzyme patterns and acetaminophen levels must be related to time and known metabolic phenomena. A careful look at ethanol and nutrition, especially fasting demonstrates that therapeutic doses of acetaminophen do not place patients at a greater risk in either of these instances. An overdose of acetaminophen in a chronic alcohol abuser may result in more severe hepatotoxicity than in the nonalcoholic. CYP2E1 and glutathione must be evaluated simultaneously rather than in isolation. Glucuronidation capacity in humans is not a factor except in massively overdosed patients. (HEPATOLOGY 2004;40:10–15.)

Ancillary